Related Experiment Video

Updated: Jun 16, 2025

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.1K

Novel-and Not So Novel-Inhibitors of the Multifunctional CRM1 Protein

Waitman K Aumann1,2, Rafi Kazi3, Amanda M Harrington4

  • 1Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, United States.

Oncology Reviews
|August 20, 2024
PubMed

Insights

Chromosome Region Maintenance 1 (CRM1), or Exportin 1 (XPO1), is key for nuclear export. Inhibiting CRM1 shows promise in treating various cancers, prompting further research into its cellular roles and novel inhibitors.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Chromosome Region Maintenance 1 (CRM1), also known as Exportin 1 (XPO1), is essential for the nuclear export of proteins and RNA via the nuclear pore complex.
  • Dysregulation of CRM1 function is implicated in various cancers, leading to the investigation of CRM1 inhibitors as a therapeutic strategy.

Purpose of the Study:

  • To review the structure and function of CRM1 in nuclear export.
  • To discuss the current landscape of CRM1 inhibitors.
  • To explore the multifaceted roles of CRM1 in cellular processes.

Main Methods:

  • Literature review of CRM1 structure and function.
  • Analysis of existing CRM1 inhibitor research.
  • Examination of CRM1's involvement in diverse cellular pathways.

Main Results:

  • CRM1's critical role in transporting proteins and RNA out of the nucleus.
  • The ongoing development and study of small molecule CRM1 inhibitors for cancer therapy.
  • CRM1's involvement in multiple cellular processes beyond basic nuclear export.

Conclusions:

  • Understanding CRM1's complex cellular functions is crucial for developing more effective CRM1 inhibitors.
  • Targeting CRM1 represents a promising avenue for novel cancer therapeutics.
  • Further research into CRM1 biology may unlock new therapeutic strategies.
Keywords:
CRM1XPO1cancerleptomycin Bnuclear export

More Related Videos

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.1K
Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion09:23

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Published on: April 2, 2020

6.4K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
16.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K